[4, 5], whose migration to the gonad requires nos function [6, 7] .
oocytes to molecular probes. Nos RNA accumulates in the oocyte both during early and mid stages of oogenesis and later as the nurse cells contract, but posterior localization has not been observed until several hours after dumping is complete and only in rare examples ([2], E.R.G, unpublished data]. The fate of these two populations of nos RNA and the reason for the delayed appearance of nos at the posterior is not known. We have overcome the difficulty of detecting endogenous RNAs during late stages of oogenesis by adapting a method for fluorescent tagging of mRNA in vivo used to visualize Ash1 RNA in yeast [29] . Previous analysis of localized RNAs in live Drosophila oocytes and embryos has relied on injection of fluorescently labeled synthetic RNAs [20, 25, 30 , 31]. However, the behavior of these RNAs may be compromised by the labeling method and requirements for nuclear and/or nurse cell transport [20, 31] . We now report the first live visualization of endogenous RNA in Drosophila oocytes and embryos and the first in a multicellular system. As we show for nos, fluorescently labeled endogenous RNA is functionally indistinguishable from wild-type RNA. long range movement of nos RNA can occur in the absence of ooplasmic streaming. Our results demonstrate that diffusion/entrapment mechanisms can generate RNA behaves indistinguishably from wild-type nos RNA asymmetric RNA distributions in cell types that lack cyin its localization and translational regulation in the early toskeletal polarity.
embryo. From early to midoogenesis, the distribution of fluorescent nos in live egg chambers recapitulates the patResults tern previously observed for wild-type nos RNA by in situ hybridization [2, 32] . Drosophila oogenesis can be GFP Labeling of nos RNA In Vivo divided into 14 morphologically distinct stages in which To investigate the nos localization pathway, we adapted the oocyte develops within an egg chamber surrounded a GFP-labeling system previously used for in vivo analyby a somatic follicle cell epithelium [33]. Through stage sis of Ash1 mRNA localization in yeast [29] . The strategy 11, the oocyte remains connected at its anterior end to requires two components: a nos transgene carrying an 15 interconnected nurse cells that synthesize nos and insertion of six tandem copies of the stem-loop binding other maternal mRNAs. In early egg chambers, fluoressite for bacteriophage MS2 coat protein (MCP) in its 3Ј cent nos RNA accumulates preferentially in the oocyte UTR (nos-(ms2) 6 ) and a second transgene encoding an and is concentrated at the oocyte posterior (Figures 2A MCP-GFP fusion protein under control of the maternally and 2D). During stages 8 and 9, the RNA accumulates active hsp83 promoter. When the two transgenes are in a ring at the anterior margin of the oocyte (Figures coexpressed, binding of MCP-GFP to its recognition 2B and 2E). As for wild-type nos, this anterior accumulamotifs in nos-(ms2) 6 RNA labels the RNA with GFP. tion is transient, and, by stage 10, there is no detectable The nos-(ms2) 6 transgene, either alone or combined with localization of fluorescent nos RNA in the oocyte (Figthe hsp83 -MCP-GFP transgene, completely rescues the ures 2C and 2F). Taken together, these results demonnos mutant abdominal defect. GFP-labeled nos-(ms2) 6 strate that fluorescent nos provides a valid proxy in the RNA (hereafter referred to as fluorescent nos RNA) is localin vivo analysis of the nos mRNA localization pathway. ized to the posterior pole of the early embryo and becomes incorporated into the pole cells ( Figures 1A and  1D) , as previously demonstrated for wild-type nos RNA nos RNA Accumulates at the Oocyte Posterior during Nurse Cell Dumping by in situ hybridization. In addition, posterior localization of fluorescent nos RNA is disrupted in osk and vas muDuring the first half of oogenesis, mRNAs are steadily transferred from the nurse cells to the oocyte. Following tants (data not shown), and the resulting embryos lack abdominal segments. By these criteria, fluorescent nos stage 10, when the oocyte has enlarged to occupy half Consistent with the inhibition of ooplasmic streaming, nos RNA at the posterior. We found that treatment of egg chambers with low concentrations of the actin decortical microtubules are no longer apparent after drug treatment is initiated (Figures 4E and 4F) . Furthermore, polymerizing agents latrunculin A (latA) or cytochalasin D (cytoD) abolishes dumping but does not affect oocyte bcd RNA localization is abolished under these conditions (data not shown). These results indicate that localcortical actin filaments or posterior localization of Vas-GFP (data not shown). We have therefore exploited this ization of fluorescent nos RNA in drug-treated oocytes is not due to residual microtubule activity. Moreover, differential sensitivity to selectively examine the role of nurse cell dumping in nos RNA localization. microtubule-independent nos localization is inconsistent with directed transport, but it can be explained by Egg chambers dissected at stage 10b were cultured for 8 hr in media containing either latA or cytoD at low a diffusion-based transport mechanism. Quantitation of posterior fluorescence intensity reveals that ‫%7ف‬ as concentration; both inhibitors gave similar results. A time-lapse movie of a representative latA-treated egg much nos RNA is present at the oocyte posterior in drug-treated egg chambers as in mock-treated controls chamber shows that while nurse cell dumping fails to occur, ooplasmic streaming is unaffected (Movie 4). By (compare Figures 4C and 4D) . Thus, wild-type localization requires both microtubule-dependent and -indecontrast, mock-treated egg chambers progress normally through stage 13 of oogenesis. While fluorescent pendent events. Taken together, our data strongly sup- Eric Wieschaus for assistance with confocal microscopy, and Tim nos-(ms2) 6 Weil for assistance with quantitation. We are also grateful to Ira The P element plasmid pCaS2-nos-(ms2) 6 
